Effects of hypoxia-inducible factor-prolyl hydroxylase inhibitors vs. erythropoiesis-stimulating agents on iron metabolism in non-dialysis-dependent anemic patients with CKD: A network meta-analysis

Effects of hypoxia-inducible factor-prolyl hydroxylase inhibitors vs. erythropoiesis-stimulating agents on iron metabolism in non-dialysis-dependent anemic patients with CKD: A network meta-analysis

ObjectiveTo compare the effects of five hypoxia-inducible factor-prolyl hydroxylase domain inhibitors (HIF-PHIs), two erythropoiesis-stimulating agents (ESAs), and placebo on iron metabolism in renal anemia patients with non-dialysis-dependent chronic kidney disease (NDD-CKD).MethodFive electronic d...

Full description

Bibliographic Details
Main Authors: Junlan Yang, Jie Xing, Xiaodong Zhu, Xiaotong Xie, Lina Wang, Xiaoliang Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Endocrinology
Subjects:
hypoxia-inducible factor prolyl hydroxylase inhibitor
erythropoiesis-stimulating agent
renal anemia
hepcidin
iron metabolism
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1131516/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1131516/full

Similar Items